| Efficient method for the preparation of peptoids [oligo (N-substituted glycines)] by submonomer solid-phase synthesis RN Zuckermann, JM Kerr, SBH Kent, WH Moos Journal of the American Chemical Society 114 (26), 10646-10647, 1992 | 1621 | 1992 |
| Discovery of nanomolar ligands for 7-transmembrane G-protein-coupled receptors from a diverse N-(substituted) glycine peptoid library RN Zuckermann, EJ Martin, DC Spellmeyer, GB Stauber, KR Shoemaker, ... Journal of medicinal chemistry 37 (17), 2678-2685, 1994 | 661 | 1994 |
| Comparison of the proteolytic susceptibilities of homologous L‐amino acid, D‐amino acid, and N‐substituted glycine peptide and peptoid oligomers SM Miller, RJ Simon, S Ng, RN Zuckermann, JM Kerr, WH Moos Drug Development Research 35 (1), 20-32, 1995 | 531 | 1995 |
| Measuring diversity: experimental design of combinatorial libraries for drug discovery EJ Martin, JM Blaney, MA Siani, DC Spellmeyer, AK Wong, WH Moos Journal of medicinal chemistry 38 (9), 1431-1436, 1995 | 481 | 1995 |
| Proteolytic studies of homologous peptide and N-substituted glycine peptoid oligomers SM Miller, RJ Simon, S Ng, RN Zuckermann, JM Kerr, WH Moos Bioorganic & medicinal chemistry letters 4 (22), 2657-2662, 1994 | 410 | 1994 |
| Apparatus for multiple simultaneous synthesis DR Cody, SHH DeWitt, JC Hodges, JS Kiely, WH Moos, MR Pavia, ... US Patent 5,324,483, 1994 | 332 | 1994 |
| A systematic screen of FDA-approved drugs for inhibitors of biological threat agents PB Madrid, S Chopra, ID Manger, L Gilfillan, TR Keepers, AC Shurtleff, ... PloS one 8 (4), e60579, 2013 | 278 | 2013 |
| The generation of molecular diversity MR Pavia, TK Sawyer, WH Moos Bioorganic & Medicinal Chemistry Letters 3 (3), 387-396, 1993 | 204 | 1993 |
| Cardiotonic agents. 1. 4, 5-Dihydro-6-[4-(1H-imidazol-1-yl) phenyl]-3 (2H)-pyridazinones: novel positive inotropic agents for the treatment of congestive heart failure JA Bristol, I Sircar, WH Moos, DB Evans, RE Weishaar Journal of medicinal chemistry 27 (9), 1099-1101, 1984 | 186 | 1984 |
| Characterization of novel antimicrobial peptoids B Goodson, A Ehrhardt, S Ng, J Nuss, K Johnson, M Giedlin, R Yamamoto, ... Antimicrobial agents and chemotherapy 43 (6), 1429-1434, 1999 | 169 | 1999 |
| Microbiota and neurological disorders: a gut feeling H MoosWalter, V FallerDouglas, N HarppDavid, R PowersWhitney BioResearch open access, 2016 | 162 | 2016 |
| Recent Advances in the Generation of Molecular Diversity WH Moos, GD Green, MF Pavia ANNUAL REPORTS IN MED CHEMISTRY V28 PPR 28, 1993 | 160 | 1993 |
| N6-cycloalkyladenosines. Potent, A1-selective adenosine agonists WH Moos, DS Szotek, RF Bruns Journal of medicinal chemistry 28 (10), 1383-1384, 1985 | 146 | 1985 |
| Cognition activators WH Moos, RE Davis, RD Schwarz, ER Gamzu Medicinal research reviews 8 (3), 353-391, 1988 | 132 | 1988 |
| Cardiotonic agents. 8. Selective inhibitors of adenosine 3', 5'-cyclic phosphate phosphodiesterase III. Elaboration of a five-point model for positive inotropic activity WH Moos, CC Humblet, I Sircar, C Rithner, RE Weishaar, JA Bristol, ... Journal of medicinal chemistry 30 (11), 1963-1972, 1987 | 107 | 1987 |
| Post-modification of peptoid side chains:[3+ 2] cycloaddition of nitrile oxides with alkenes and alkynes on the solid-phase Y Pei, WH Moos Tetrahedron letters 35 (32), 5825-5828, 1994 | 92 | 1994 |
| Development of 17α‐Estradiol as a Neuroprotective Therapeutic Agent: Rationale and Results from a Phase I Clinical Study JA Dykens, WH Moos, N Howell Annals of the New York Academy of Sciences 1052 (1), 116-135, 2005 | 89 | 2005 |
| Combinatorial discovery process yields antimicrobial peptoids S Ng, B Goodson, A Ehrhardt, WH Moos, M Siani, J Winter Bioorganic & medicinal chemistry 7 (9), 1781-1785, 1999 | 84 | 1999 |
| Cardiotonic agents. 7. Inhibition of separated forms of cyclic nucleotide phosphodiesterase from guinea pig cardiac muscle by 4, 5-dihydro-6-[4-(1H-imidazol-1-yl) phenyl]-3 (2H … I Sircar, RE Weishaar, D Kobylarz, WH Moos, JA Bristol Journal of medicinal chemistry 30 (11), 1955-1962, 1987 | 83 | 1987 |
| Recent advances in the generation of chemical diversity libraries MC Desai, RN Zuckermann, WH Moos Drug development research 33 (2), 174-188, 1994 | 79 | 1994 |
Ronald N. ZuckermannMolecular Foundry, Lawrence Berkeley National LaboratoryVerified email at lbl.gov
